4//SEC Filing
Boyle Kevin S. Sr. 4
Accession 0000899243-23-009000
CIK 0001107421other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 8:30 PM ET
Size
5.6 KB
Accession
0000899243-23-009000
Insider Transaction Report
Form 4
Boyle Kevin S. Sr.
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-15+1,800,000→ 1,800,000 totalExercise: $0.50Exp: 2033-03-14→ Common Stock (1,800,000 underlying)
Footnotes (1)
- [F1]One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from January 1, 2023, with the first vesting occuring on April 1, 2023, subject to the Reporting Person's continued service through each such date.
Documents
Issuer
Alaunos Therapeutics, Inc.
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001880600
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 8:30 PM ET
- Size
- 5.6 KB